BioCentury | Jan 20, 2014
Company News

BioBlocks, Visionary Pharmaceuticals deal

...the kinase has been implicated in breast, prostate, colorectal and non-small cell lung cancer (NSCLC). BioBlocks...
...and then seek a partner for further development. The partners declined to disclose financial details. BioBlocks Inc....
BioCentury | Nov 24, 2008
Company News

BioBlocks, MannKind deal

...The companies extended by one year their January 2007 deal to use BioBlocks' medicinal chemistry technology...
...targets. The partnership has already met an undisclosed preclinical milestone. Financial terms were not disclosed. BioBlocks Inc....
Items per page:
1 - 2 of 2
BioCentury | Jan 20, 2014
Company News

BioBlocks, Visionary Pharmaceuticals deal

...the kinase has been implicated in breast, prostate, colorectal and non-small cell lung cancer (NSCLC). BioBlocks...
...and then seek a partner for further development. The partners declined to disclose financial details. BioBlocks Inc....
BioCentury | Nov 24, 2008
Company News

BioBlocks, MannKind deal

...The companies extended by one year their January 2007 deal to use BioBlocks' medicinal chemistry technology...
...targets. The partnership has already met an undisclosed preclinical milestone. Financial terms were not disclosed. BioBlocks Inc....
Items per page:
1 - 2 of 2